Your browser doesn't support javascript.
loading
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo, Sarah E; He, Yuyu; Daughters, Claire; Knutson, Todd P; Henzler, Christine M; Price, Matthew A; Shanley, Ryan; Witschen, Patrice; Tolg, Cornelia; Kaspar, Rachael E; Hallstrom, Caroline; Gittsovich, Lyubov; Sulciner, Megan L; Zhang, Xihong; Forster, Colleen L; Lange, Carol A; Shats, Oleg; Desler, Michelle; Cowan, Kenneth H; Yee, Douglas; Schwertfeger, Kathryn L; Turley, Eva A; McCarthy, James B; Nelson, Andrew C.
Affiliation
  • Tarullo SE; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • He Y; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Daughters C; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Knutson TP; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Henzler CM; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Price MA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Shanley R; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Witschen P; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.
  • Tolg C; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Kaspar RE; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.
  • Hallstrom C; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Gittsovich L; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Sulciner ML; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Zhang X; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Forster CL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Lange CA; London Health Sciences Center, Western University, Ontario, Canada.
  • Shats O; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Desler M; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Cowan KH; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Yee D; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Schwertfeger KL; School of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Turley EA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • McCarthy JB; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Nelson AC; Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA.
J Pathol ; 260(3): 289-303, 2023 07.
Article in En | MEDLINE | ID: mdl-37186300
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Pathol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Pathol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido